Ruud Wiggenraad
Research Subjects
Ruud Wiggenraad has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Antoinette Verbeek-De Kanter
Radiotherapy Centre West
3 shared publicationsHenk Struikmans
Radiotherapy Centre West
3 shared publications- Jan P. C. van Santvoort
Department of Medical Physics, Haaglanden Medical Center, The Hague, the Netherlands
3 shared publications Martin Taphoorn
Medical Centre Haaglanden
2 shared publicationsA. Verbeek-De Kanter
Radiotherapy Centre West
1 shared publication- Anna L. Petoukhova
Department of Medical Physics, Haaglanden Medical Center, Leidschendam, the Netherlands
1 shared publication
Latest Publications
- 5 July 2014
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 119 (2) , 437-443
Pseudo-progression after stereotactic radiotherapy of brain metastases: lesion analysis using MRI cine-loops
Stereotactic radiotherapy (SRT) of brain metastasis can lead to lesion growth caused by radiation toxicity. The pathophysiology of this so-called pseudo-progression is poorly understood. The purpose of this study was to evaluate the use of MRI cine-loops for describing the consecutive events in this radiation induced lesion growth. Ten patients were selected from our department’s database that had received SRT of brain metastases and had lesion growth caused by pseudo-progression as well as at least five follow-up MRI scans. Pre- and post SRT MRI scans were co-registered and cine-loops were made using post-gadolinium 3D T1 axial slices. The ten cine loops were discussed in a joint meeting of the authors. The use of cine-loops was superior to evaluation of separate MRI scans for interpretation of events after SRT. There was a typical lesion evolution pattern in all patients with varying time course. Initially regression of the metastases was observed, followed by an enlarging area of new contrast enhancement in the surrounding brain tissue. Analysis of consecutive MRI’s using cine-loops may improve understanding of pseudo-progression. It probably represents a radiation effect in brain tissue surrounding the irradiated metastasis and not enlargement of the metastasis itself.
- 5 July 2014
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 119 (2) , 437-443
Pseudo-progression after stereotactic radiotherapy of brain metastases: lesion analysis using MRI cine-loops
Stereotactic radiotherapy (SRT) of brain metastasis can lead to lesion growth caused by radiation toxicity. The pathophysiology of this so-called pseudo-progression is poorly understood. The purpose of this study was to evaluate the use of MRI cine-loops for describing the consecutive events in this radiation induced lesion growth. Ten patients were selected from our department’s database that had received SRT of brain metastases and had lesion growth caused by pseudo-progression as well as at least five follow-up MRI scans. Pre- and post SRT MRI scans were co-registered and cine-loops were made using post-gadolinium 3D T1 axial slices. The ten cine loops were discussed in a joint meeting of the authors. The use of cine-loops was superior to evaluation of separate MRI scans for interpretation of events after SRT. There was a typical lesion evolution pattern in all patients with varying time course. Initially regression of the metastases was observed, followed by an enlarging area of new contrast enhancement in the surrounding brain tissue. Analysis of consecutive MRI’s using cine-loops may improve understanding of pseudo-progression. It probably represents a radiation effect in brain tissue surrounding the irradiated metastasis and not enlargement of the metastasis itself.
- 23 June 2012
- Published by Springer Nature in Strahlentherapie und Onkologie
- Vol. 188 (8) , 696-701
Local progression and pseudo progression after single fraction or fractionated stereotactic radiotherapy for large brain metastases
The 1-year local control rates after single-fraction stereotactic radiotherapy (SRT) for brain metastases > 3 cm diameter are less than 70%, but with fractionated SRT (FSRT) higher local control rates have been reported. The purpose of this study was to compare our treatment results with SRT and FSRT for large brain metastases. In two consecutive periods, 41 patients with 46 brain metastases received SRT with 1 fraction of 15 Gy, while 51 patients with 65 brain metastases received FSRT with 3 fractions of 8 Gy. We included patients with brain metastases with a planning target volume of > 13 cm3 or metastases in the brainstem. The minimum follow-up of patients still alive was 22 months. Comparing 1 fraction of 15 Gy with 3 fractions of 8 Gy, the 1-year rates of freedom from any local progression (54% and 61%, p = 0.93) and pseudo progression (85% and 75%, p = 0.25) were not significantly different. Overall survival rates were also not different. The 1-year local progression and pseudo progression rates after 1 fraction of 15 Gy or 3 fractions of 8 Gy for large brain metastases and metastases in the brainstem are similar. For better local control rates, FSRT schemes with a higher biological equivalent dose may be necessary. Die einjährige lokale Tumorkontrollrate von Hirnmetastasen mit einem Durchmesser von mind. 3 cm beträgt nach stereotaktischer Bestrahlung mit einer Fraktion (SRT) weniger als 70%. Höhere lokale Tumorkontrollraten sind nach fraktionierter stereotaktischer Bestrahlung (FSRT) beschrieben worden. In dieser Studie werden die Behandlungsergebnisse der SRT und der FSRT für größere Hirnmetastasen verglichen. In 2 aufeinanderfolgenden Perioden wurden 41 Patienten mit 46 Hirnmetastasen mit 1 -mal 15 Gy SRT und 51 Patienten mit 65 Hirnmetastasen mit 3 -mal 8 Gy FSRT behandelt. Alle inkludierten Patienten hatten einen PTV von mindestens 13 cm3 oder Metastasen im Hirnstammbereich. Das minimale Follow-up von überlebenden Patienten betrug 22 Monate. Beim Vergleich der Resultate von 1 -mal 15 Gy mit 3 -mal 8 Gy ergaben sich nach einem Jahr keine signifikanten Unterschiede bei den Raten ohne lokale Progression (54% bzw. 61%; p = 0,93), der Pseudoprogression (85% bzw. 75%; p = 0,25) und im Gesamtϋberleben. Die lokale Progression und Pseudoprogression von großen Hirnmetastasen oder Hirnstammmetastasen sind ein Jahr nach Behandlung mit 1 -mal 15 Gy oder 3 -mal 8 Gy vergleichbar. Fϋr eine bessere lokale Kontrolle sind vielleicht FSRT-Regime mit höherer biologischer Äquivalentdosis notwendig.
- 23 June 2012
- Published by Springer Nature in Strahlentherapie und Onkologie
- Vol. 188 (8) , 696-701
Local progression and pseudo progression after single fraction or fractionated stereotactic radiotherapy for large brain metastases
The 1-year local control rates after single-fraction stereotactic radiotherapy (SRT) for brain metastases > 3 cm diameter are less than 70%, but with fractionated SRT (FSRT) higher local control rates have been reported. The purpose of this study was to compare our treatment results with SRT and FSRT for large brain metastases. In two consecutive periods, 41 patients with 46 brain metastases received SRT with 1 fraction of 15 Gy, while 51 patients with 65 brain metastases received FSRT with 3 fractions of 8 Gy. We included patients with brain metastases with a planning target volume of > 13 cm3 or metastases in the brainstem. The minimum follow-up of patients still alive was 22 months. Comparing 1 fraction of 15 Gy with 3 fractions of 8 Gy, the 1-year rates of freedom from any local progression (54% and 61%, p = 0.93) and pseudo progression (85% and 75%, p = 0.25) were not significantly different. Overall survival rates were also not different. The 1-year local progression and pseudo progression rates after 1 fraction of 15 Gy or 3 fractions of 8 Gy for large brain metastases and metastases in the brainstem are similar. For better local control rates, FSRT schemes with a higher biological equivalent dose may be necessary. Die einjährige lokale Tumorkontrollrate von Hirnmetastasen mit einem Durchmesser von mind. 3 cm beträgt nach stereotaktischer Bestrahlung mit einer Fraktion (SRT) weniger als 70%. Höhere lokale Tumorkontrollraten sind nach fraktionierter stereotaktischer Bestrahlung (FSRT) beschrieben worden. In dieser Studie werden die Behandlungsergebnisse der SRT und der FSRT für größere Hirnmetastasen verglichen. In 2 aufeinanderfolgenden Perioden wurden 41 Patienten mit 46 Hirnmetastasen mit 1 -mal 15 Gy SRT und 51 Patienten mit 65 Hirnmetastasen mit 3 -mal 8 Gy FSRT behandelt. Alle inkludierten Patienten hatten einen PTV von mindestens 13 cm3 oder Metastasen im Hirnstammbereich. Das minimale Follow-up von überlebenden Patienten betrug 22 Monate. Beim Vergleich der Resultate von 1 -mal 15 Gy mit 3 -mal 8 Gy ergaben sich nach einem Jahr keine signifikanten Unterschiede bei den Raten ohne lokale Progression (54% bzw. 61%; p = 0,93), der Pseudoprogression (85% bzw. 75%; p = 0,25) und im Gesamtϋberleben. Die lokale Progression und Pseudoprogression von großen Hirnmetastasen oder Hirnstammmetastasen sind ein Jahr nach Behandlung mit 1 -mal 15 Gy oder 3 -mal 8 Gy vergleichbar. Fϋr eine bessere lokale Kontrolle sind vielleicht FSRT-Regime mit höherer biologischer Äquivalentdosis notwendig.
- 1 March 2011
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 98 (3) , 292-297
Dose–effect relation in stereotactic radiotherapy for brain metastases. A systematic review
- 1 March 2011
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 98 (3) , 292-297
Dose–effect relation in stereotactic radiotherapy for brain metastases. A systematic review
- 1 July 2009
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 74 (4) , 1018-1026
Stereotactic Radiotherapy of Intracranial Tumors: A Comparison of Intensity-Modulated Radiotherapy and Dynamic Conformal Arc
- 1 July 2009
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 74 (4) , 1018-1026
Stereotactic Radiotherapy of Intracranial Tumors: A Comparison of Intensity-Modulated Radiotherapy and Dynamic Conformal Arc
- 1 January 2009
- Published by Taylor & Francis in British Journal Of Neurosurgery
- Vol. 23 (2) , 170-178
Relationship between volume, dose and local control in stereotactic radiosurgery of brain metastasis
The aim of this study is to analyse the efficacy of linear accelerator stereotactic radiosurgery (SRS) on prognostic factors, local control rate and survival in patients with brain metastasis. Patients with either a single metastasis or up to 4 multiple brain metastases with a maximum tumour diameter of 40 mm for each tumour and a Karnofsky Performance Status (KPS) ≥ 70 were eligible for SRS. SRS was applied to 150 lesions in 86 consecutive patients with a median age of 60 years (median 1 and mean 1.7 lesions per patient, mean KPS 86). Median overall survival was 6.2 months after SRS and 9.7 months from diagnosis of brain metastasis. Multivariate analysis revealed that a KPS of 90 or more (p = 0.009) and female sex (p = 0.003) were associated with a longer survival. Radiation dose ≤15 Gy (p = 0.017) and KPS < 90 (p = 0.013) were independent predictors of a shorter time to local failure. Five patients showed evidence of radionecrosis with a median survival of 14.8 months. Addition of WBRT neither led to improvement of survival nor to improvement of local control. Improved local control following SRS for brain metastases was associated with KPS ≥90, a radiation dose > 15 Gy and a PTV < 13 cc. The potential of hypofractionated stereotactic radiotherapy (SRT) for brain metastases of larger volume warrants further study.
- 1 January 2009
- Published by Taylor & Francis in British Journal Of Neurosurgery
- Vol. 23 (2) , 170-178
Relationship between volume, dose and local control in stereotactic radiosurgery of brain metastasis
The aim of this study is to analyse the efficacy of linear accelerator stereotactic radiosurgery (SRS) on prognostic factors, local control rate and survival in patients with brain metastasis. Patients with either a single metastasis or up to 4 multiple brain metastases with a maximum tumour diameter of 40 mm for each tumour and a Karnofsky Performance Status (KPS) ≥ 70 were eligible for SRS. SRS was applied to 150 lesions in 86 consecutive patients with a median age of 60 years (median 1 and mean 1.7 lesions per patient, mean KPS 86). Median overall survival was 6.2 months after SRS and 9.7 months from diagnosis of brain metastasis. Multivariate analysis revealed that a KPS of 90 or more (p = 0.009) and female sex (p = 0.003) were associated with a longer survival. Radiation dose ≤15 Gy (p = 0.017) and KPS < 90 (p = 0.013) were independent predictors of a shorter time to local failure. Five patients showed evidence of radionecrosis with a median survival of 14.8 months. Addition of WBRT neither led to improvement of survival nor to improvement of local control. Improved local control following SRS for brain metastases was associated with KPS ≥90, a radiation dose > 15 Gy and a PTV < 13 cc. The potential of hypofractionated stereotactic radiotherapy (SRT) for brain metastases of larger volume warrants further study.
- 1 October 2005
- Published by Springer Nature in Strahlentherapie und Onkologie
- Vol. 181 (10) , 673-682
ConPas: a 3-D Conformal Parotid Gland-Sparing Irradiation Technique for Bilateral Neck Treatment as an Alternative to IMRT
Background and Purpose: Intensity-modulated radiotherapy (IMRT) is used in most reported techniques for bilateral neck irradiation that aim at parotid gland sparing. A relatively simple conformal parotid-sparing technique (ConPas) was developed that uses no beam-intensity modulation. The purpose of this paper is to demonstrate, in patients with larynx or hypopharynx carcinoma, that ConPas enables adequate coverage of the primary tumor and the bilateral neck nodes, while keeping the mean parotid dose (MPD) < 26 Gy. Patients and Methods: Treatment plans using ConPas and the conventional technique (using one anteroposterior supraclavicular and two lateral beams) were computed for ten consecutive patients with T1–4 N0–1 larynx or hypopharynx carcinoma (not T1 glottic). A dose of 46 Gy was prescribed to the primary tumor and the bilateral neck nodes, planned either with the conventional technique or ConPas, followed by a boost up to 70 Gy with a simple two-field technique. The target coverage of both techniques was compared using the V95, the percentage of the planning target volume (PTV) of the primary tumor and nodal regions receiving at least 95% of the prescribed elective dose. The MPDs and the normal-tissue complication probabilities (NTCPs) of the parotid glands were compared using either technique including the boost up to 70 Gy. Dosimetric verification of the technique has been carried out, using ionization chamber measurements and film dosimetry. Results: The mean V95 was 85.2% and 91.2% (p = 0.08), the mean MPD 38.7 Gy and 25.4 Gy (p < 0.001), and the mean NTCP for the parotid glands 0.87 and 0.22 (p < 0.001) for the conventional technique and ConPas, respectively. The dosimetric verification shows a good agreement between dose calculation and measurement. Conclusion: ConPas enables adequate target coverage and clinically relevant parotid sparing in bilateral neck irradiation without beam-intensity modulation.
- 1 October 2005
- Published by Springer Nature in Strahlentherapie und Onkologie
- Vol. 181 (10) , 673-682
ConPas: a 3-D Conformal Parotid Gland-Sparing Irradiation Technique for Bilateral Neck Treatment as an Alternative to IMRT
Background and Purpose: Intensity-modulated radiotherapy (IMRT) is used in most reported techniques for bilateral neck irradiation that aim at parotid gland sparing. A relatively simple conformal parotid-sparing technique (ConPas) was developed that uses no beam-intensity modulation. The purpose of this paper is to demonstrate, in patients with larynx or hypopharynx carcinoma, that ConPas enables adequate coverage of the primary tumor and the bilateral neck nodes, while keeping the mean parotid dose (MPD) < 26 Gy. Patients and Methods: Treatment plans using ConPas and the conventional technique (using one anteroposterior supraclavicular and two lateral beams) were computed for ten consecutive patients with T1–4 N0–1 larynx or hypopharynx carcinoma (not T1 glottic). A dose of 46 Gy was prescribed to the primary tumor and the bilateral neck nodes, planned either with the conventional technique or ConPas, followed by a boost up to 70 Gy with a simple two-field technique. The target coverage of both techniques was compared using the V95, the percentage of the planning target volume (PTV) of the primary tumor and nodal regions receiving at least 95% of the prescribed elective dose. The MPDs and the normal-tissue complication probabilities (NTCPs) of the parotid glands were compared using either technique including the boost up to 70 Gy. Dosimetric verification of the technique has been carried out, using ionization chamber measurements and film dosimetry. Results: The mean V95 was 85.2% and 91.2% (p = 0.08), the mean MPD 38.7 Gy and 25.4 Gy (p < 0.001), and the mean NTCP for the parotid glands 0.87 and 0.22 (p < 0.001) for the conventional technique and ConPas, respectively. The dosimetric verification shows a good agreement between dose calculation and measurement. Conclusion: ConPas enables adequate target coverage and clinically relevant parotid sparing in bilateral neck irradiation without beam-intensity modulation.
- 1 May 2005
- Published by Taylor & Francis in International Journal of Hyperthermia
- Vol. 21 (3) , 185-192
Two cases of fatal necrosis of the lesser pelvis in patients treated with combined radiotherapy and hyperthermia for cervical carcinoma
This study reports two cases of fatal necrosis of the lesser pelvis in patients with advanced cervical carcinoma, who had received combined radiotherapy and hyperthermia. The necrosis reached far from the high dose area, in one of the cases even outside the radiation portals. Both patients initially had treatment-related morbidity which responded well to surgical treatment. After a disease-free interval, a rapidly progressive necrosis developed. Necrosis to this extent after combined modality treatment has, to the authors’ knowledge, not been described.
- 1 May 2005
- Published by Taylor & Francis in International Journal of Hyperthermia
- Vol. 21 (3) , 185-192
Two cases of fatal necrosis of the lesser pelvis in patients treated with combined radiotherapy and hyperthermia for cervical carcinoma
This study reports two cases of fatal necrosis of the lesser pelvis in patients with advanced cervical carcinoma, who had received combined radiotherapy and hyperthermia. The necrosis reached far from the high dose area, in one of the cases even outside the radiation portals. Both patients initially had treatment-related morbidity which responded well to surgical treatment. After a disease-free interval, a rapidly progressive necrosis developed. Necrosis to this extent after combined modality treatment has, to the authors’ knowledge, not been described.